These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16883119)

  • 1. Pharmacokinetics and the most suitable regimen of panipenem/beta mipron in critically ill patients receiving continuous renal replacement therapy: a pilot study.
    Hayakawa M; Ito Y; Fujita I; Iseki K; Gando S
    ASAIO J; 2006; 52(4):398-403. PubMed ID: 16883119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The administration of ciprofloxacin during continuous renal replacement therapy: pilot study.
    Hayakawa M; Fujita I; Iseki K; Gando S
    ASAIO J; 2009; 55(3):243-5. PubMed ID: 19318919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug dosing during continuous renal replacement therapy.
    Churchwell MD; Mueller BA
    Semin Dial; 2009; 22(2):185-8. PubMed ID: 19426426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.
    Isla A; Rodríguez-Gascón A; Trocóniz IF; Bueno L; Solinís MA; Maynar J; Sánchez-Izquierdo JA; Pedraz JL
    Clin Pharmacokinet; 2008; 47(3):173-80. PubMed ID: 18307371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous renal replacement therapy in critically ill patients.
    Zobel G; Rödl S; Urlesberger B; Kuttnig-Haim M; Ring E
    Kidney Int Suppl; 1998 May; 66():S169-73. PubMed ID: 9573597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy.
    Eachempati SR; Wang JC; Hydo LJ; Shou J; Barie PS
    J Trauma; 2007 Nov; 63(5):987-93. PubMed ID: 17993940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
    Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
    Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of meropenem in children receiving continuous renal replacement therapy: Validation of clinical trial simulations.
    Nehus EJ; Mizuno T; Cox S; Goldstein SL; Vinks AA
    J Clin Pharmacol; 2016 Mar; 56(3):291-7. PubMed ID: 26222329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA; Udy AA; Lipman J; Roberts JA
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
    J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis.
    Asín-Prieto E; Rodríguez-Gascón A; Trocóniz IF; Soraluce A; Maynar J; Sánchez-Izquierdo JÁ; Isla A
    J Antimicrob Chemother; 2014 Jan; 69(1):180-9. PubMed ID: 23908259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.
    Trotman RL; Williamson JC; Shoemaker DM; Salzer WL
    Clin Infect Dis; 2005 Oct; 41(8):1159-66. PubMed ID: 16163635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 90-day mortality and the subsequent renal recovery in critically ill surgical patients requiring acute renal replacement therapy.
    Lin YF; Ko WJ; Chu TS; Chen YS; Wu VC; Chen YM; Wu MS; Chen YW; Tsai CW; Shiao CC; Li WY; Hu FC; Tsai PR; Tsai TJ; Wu KD;
    Am J Surg; 2009 Sep; 198(3):325-32. PubMed ID: 19716882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.